This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Texas A&M University System, The University of Texas System. Active years: 2023.
Company Filing History:
1 out of 1,321 
1 out of 5,627 
Years Active: 2023
Title: Katy Kao: Innovator in Metabolite Screening Technologies
Introduction
Katy Kao is a prominent inventor based in College Station, TX (US). She has made significant contributions to the field of metabolite screening and selection. Her innovative work has led to the development of unique methods and platforms that enhance the understanding of metabolites and their receptors.
Latest Patents
Katy Kao holds 1 patent for her invention titled "Methods and platform for screening and selecting metabolites and their receptors." This patent discloses methods and platforms utilizing Receptor Compartmentalized Partnered Replication (CPR). The process involves coupling a signal transduction pathway or receptor to the production of a thermostable polymerase. By emulsifying libraries of organisms with primers that amplify the partner gene, the method selectively amplifies those partner genes that effectively produce the thermostable polymerase during thermal cycling.
Career Highlights
Throughout her career, Katy has worked with esteemed institutions such as the University of Texas System and Texas A&M University System. Her experience in these organizations has allowed her to advance her research and contribute to the scientific community.
Collaborations
Katy has collaborated with notable colleagues, including Andrew D. Ellington and Elizabeth Gardner. These partnerships have further enriched her research and innovation in the field.
Conclusion
Katy Kao is a trailblazer in the realm of metabolite screening technologies. Her innovative patent and collaborations with leading institutions and colleagues highlight her significant impact on the scientific community.